{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:19:02Z","timestamp":1778635142198,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP20K07392"],"award-info":[{"award-number":["JP20K07392"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01185-z","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T23:10:41Z","timestamp":1695597041000},"page":"5191-5200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CD44v6 downregulation as a prognostic factor for distant recurrence in resected stage I lung adenocarcinomas"],"prefix":"10.1007","volume":"23","author":[{"given":"Chihiro","family":"Yoshida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyuichi","family":"Kadota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaede","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syusuke","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emi","family":"Ibuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryou","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiji","family":"Haba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Yajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"key":"1185_CR1","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science. 2013;339:1546\u201358. https:\/\/doi.org\/10.1126\/science.1235122.","journal-title":"Science"},{"key":"1185_CR2","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.3892\/ol.2014.1861","volume":"7","author":"H Sasaki","year":"2014","unstructured":"Sasaki H, Suzuki A, Tatematsu T, et al. Prognosis of recurrent non-small cell lung cancer following complete resection. Oncol Lett. 2014;7:1300\u20134. https:\/\/doi.org\/10.3892\/ol.2014.1861.","journal-title":"Oncol Lett"},{"key":"1185_CR3","doi-asserted-by":"publisher","first-page":"e132","DOI":"10.1016\/j.cllc.2020.09.002","volume":"22","author":"CN Ekeke","year":"2021","unstructured":"Ekeke CN, Mitchell C, Schuchert M, Dhupar R, Luketich JD, Okusanya OT. Early distant recurrence in patients with resected stage I lung cancer: A case series of \u201cBlast Metastasis.\u201d Clin Lung Cancer. 2021;22:e132\u20135. https:\/\/doi.org\/10.1016\/j.cllc.2020.09.002.","journal-title":"Clin Lung Cancer"},{"key":"1185_CR4","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3389\/fcell.2018.00097","volume":"6","author":"Z Wang","year":"2018","unstructured":"Wang Z, Zhao K, Hackert T, Z\u00f6ller M. CD44\/CD44v6 a reliable companion in cancer-initiating cell maintenance and tumor progression. Front Cell Dev Biol. 2018;6:97. https:\/\/doi.org\/10.3389\/fcell.2018.00097.","journal-title":"Front Cell Dev Biol"},{"key":"1185_CR5","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1111\/cas.12765","volume":"106","author":"F Tjhay","year":"2015","unstructured":"Tjhay F, Motohara T, Tayama S, et al. CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer. Cancer Sci. 2015;106:1421\u20138. https:\/\/doi.org\/10.1111\/cas.12765.","journal-title":"Cancer Sci"},{"key":"1185_CR6","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1007\/s00432-010-0779-x","volume":"136","author":"P Yu","year":"2010","unstructured":"Yu P, Zhou L, Ke W, Li K. Clinical significance of pAKT and CD44v6 overexpression with breast cancer. J Cancer Res Clin Oncol. 2010;136:1283\u201392. https:\/\/doi.org\/10.1007\/s00432-010-0779-x.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1185_CR7","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/s0046-8177(98)80014-2","volume":"29","author":"D Coppola","year":"1998","unstructured":"Coppola D, Hyacinthe M, Fu L, et al. CD44V6 expression in human colorectal carcinoma. Hum Pathol. 1998;29:627\u201335. https:\/\/doi.org\/10.1016\/s0046-8177(98)80014-2.","journal-title":"Hum Pathol"},{"key":"1185_CR8","doi-asserted-by":"publisher","first-page":"4549","DOI":"10.3748\/wjg.v18.i33.4549","volume":"18","author":"ST Avoranta","year":"2012","unstructured":"Avoranta ST, Korkeila EA, Syrj\u00e4nen KJ, Pyrh\u00f6nen SO, Sundstr\u00f6m JT. Lack of CD44 variant 6 expression in rectal cancer invasive front associates with early recurrence. World J Gastroenterol. 2012;18:4549\u201356. https:\/\/doi.org\/10.3748\/wjg.v18.i33.4549.","journal-title":"World J Gastroenterol"},{"key":"1185_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.anndiagpath.2015.10.010","volume":"20","author":"A Afify","year":"2016","unstructured":"Afify A, Durbin-Johnson B, Virdi A, Jess H. The expression of CD44v6 in colon: from normal to malignant. Ann Diagn Pathol. 2016;20:19\u201323. https:\/\/doi.org\/10.1016\/j.anndiagpath.2015.10.010.","journal-title":"Ann Diagn Pathol"},{"key":"1185_CR10","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1093\/jnci\/djt166","volume":"105","author":"J Nitadori","year":"2013","unstructured":"Nitadori J, Bograd AJ, Kadota K, et al. Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2\u00a0cm or smaller. J Natl Cancer Inst. 2013;105:1212\u201320. https:\/\/doi.org\/10.1093\/jnci\/djt166.","journal-title":"J Natl Cancer Inst"},{"key":"1185_CR11","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1378\/chest.12-0790","volume":"142","author":"J Donington","year":"2012","unstructured":"Donington J, Ferguson M, Mazzone P, et al. American college of chest physicians and society of thoracic surgeons consensus statement for evaluation and management for high-risk patients with stage I non-small cell lung cancer. Chest. 2012;142:1620\u201335. https:\/\/doi.org\/10.1378\/chest.12-0790.","journal-title":"Chest"},{"key":"1185_CR12","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/978-3-319-40618-3","volume-title":"AJCC cancer staging manual","author":"MB Amin","year":"2017","unstructured":"Amin MB, Edge S, Greene F, et al. AJCC cancer staging manual. 8th ed. New Yok: Springer; 2017. p. 431\u201356.","edition":"8"},{"key":"1185_CR13","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jtho.2021.11.003","volume":"17","author":"AG Nicholson","year":"2022","unstructured":"Nicholson AG, Tsao MS, Beasley MB, et al. The 2021 WHO classification of lung tumors: impact of advances since 2015. J Thorac Oncol. 2022;17:362\u201387. https:\/\/doi.org\/10.1016\/j.jtho.2021.11.003.","journal-title":"J Thorac Oncol"},{"key":"1185_CR14","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1158\/1078-0432.CCR-12-0455","volume":"18","author":"R Chappell","year":"2012","unstructured":"Chappell R. Competing risk analyses: how are they different and why should you care? Clin Cancer Res. 2012;18:2127\u20139. https:\/\/doi.org\/10.1158\/1078-0432.CCR-12-0455.","journal-title":"Clin Cancer Res"},{"key":"1185_CR15","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-11-2097","volume":"18","author":"JJ Dignam","year":"2012","unstructured":"Dignam JJ, Zhang Q, Kocherginsky M. The use and interpretation of competing risks regression models. Clin Cancer Res. 2012;18:2301\u20138. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-2097.","journal-title":"Clin Cancer Res"},{"key":"1185_CR16","first-page":"1141","volume":"16","author":"RJ Gray","year":"1998","unstructured":"Gray RJ. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat. 1998;16:1141\u201354.","journal-title":"Ann Stat"},{"key":"1185_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/s0065-230x(08)60101-3","volume":"71","author":"D Naor","year":"1997","unstructured":"Naor D, Sionov RV, Ish-Shalom D. CD44: structure, function, and association with the malignant process. Adv Cancer Res. 1997;71:241\u2013319. https:\/\/doi.org\/10.1016\/s0065-230x(08)60101-3.","journal-title":"Adv Cancer Res"},{"key":"1185_CR18","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1172\/JCI44540","volume":"121","author":"RL Brown","year":"2011","unstructured":"Brown RL, Reinke LM, Damerow MS, et al. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest. 2011;121:1064\u201374. https:\/\/doi.org\/10.1172\/JCI44540.","journal-title":"J Clin Invest"},{"key":"1185_CR19","doi-asserted-by":"publisher","first-page":"561","DOI":"10.3109\/1061186X.2012.702767","volume":"20","author":"LM Negi","year":"2012","unstructured":"Negi LM, Talegaonkar S, Jaggi M, Ahmad FJ, Iqbal Z, Khar RK. Role of CD44 in tumour progression and strategies for targeting. J Drug Target. 2012;20:561\u201373. https:\/\/doi.org\/10.3109\/1061186X.2012.702767.","journal-title":"J Drug Target"},{"key":"1185_CR20","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.3390\/biom5043051","volume":"5","author":"JD Sacks","year":"2015","unstructured":"Sacks JD, Barbolina MV. Expression and function of CD44 in epithelial ovarian carcinoma. Biomolecules. 2015;5:3051\u201366. https:\/\/doi.org\/10.3390\/biom5043051.","journal-title":"Biomolecules"},{"key":"1185_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40164-020-00192-0","volume":"9","author":"H Xu","year":"2020","unstructured":"Xu H, Niu M, Yuan X, Wu K, Liu A. CD44 as a tumor biomarker and therapeutic target. Exp Hematol Oncol. 2020;9:36. https:\/\/doi.org\/10.1186\/s40164-020-00192-0.","journal-title":"Exp Hematol Oncol"},{"key":"1185_CR22","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1158\/1078-0432.CCR-15-3115","volume":"22","author":"S Zhao","year":"2016","unstructured":"Zhao S, Chen C, Chang K, et al. CD44 expression level and isoform contributes to pancreatic cancer cell plasticity, invasiveness, and response to therapy. Clin Cancer Res. 2016;22:5592\u2013604. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-3115.","journal-title":"Clin Cancer Res"},{"key":"1185_CR23","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.3892\/or.2013.2273","volume":"29","author":"S Saito","year":"2013","unstructured":"Saito S, Okabe H, Watanabe M, et al. CD44v6 expression is related to mesenchymal phenotype and poor prognosis in patients with colorectal cancer. Oncol Rep. 2013;29:1570\u20138. https:\/\/doi.org\/10.3892\/or.2013.2273.","journal-title":"Oncol Rep"},{"key":"1185_CR24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s13277-013-0662-x","volume":"34","author":"S Tuncay Cagatay","year":"2013","unstructured":"Tuncay Cagatay S, Cimen I, Savas B, Banerjee S. MTA-1 expression is associated with metastasis and epithelial to mesenchymal transition in colorectal cancer cells. Tumour Biol. 2013;34:1189\u2013204. https:\/\/doi.org\/10.1007\/s13277-013-0662-x.","journal-title":"Tumour Biol"},{"key":"1185_CR25","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","volume":"11","author":"C Chen","year":"2018","unstructured":"Chen C, Zhao S, Karnad A, Freeman JW. The biology and role of CD44 in cancer progression: therapeutic implications. J Hematol Oncol. 2018;11:64. https:\/\/doi.org\/10.1186\/s13045-018-0605-5.","journal-title":"J Hematol Oncol"},{"key":"1185_CR26","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stem.2014.01.009","volume":"14","author":"M Todaro","year":"2014","unstructured":"Todaro M, Gaggianesi M, Catalano V, et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 2014;14:342\u201356. https:\/\/doi.org\/10.1016\/j.stem.2014.01.009.","journal-title":"Cell Stem Cell"},{"key":"1185_CR27","first-page":"692","volume":"8","author":"LH Zhao","year":"2015","unstructured":"Zhao LH, Lin QL, Wei J, Huai YL, Wang KJ, Yan HY. CD44v6 expression in patients with stage II or stage III sporadic colorectal cancer is superior to CD44 expression for predicting progression. Int J Clin Exp Pathol. 2015;8:692\u2013701.","journal-title":"Int J Clin Exp Pathol"},{"key":"1185_CR28","first-page":"14283","volume":"8","author":"L Wang","year":"2015","unstructured":"Wang L, Liu Q, Lin D, Lai M. CD44v6 down-regulation is an independent prognostic factor for poor outcome of colorectal carcinoma. Int J Clin Exp Pathol. 2015;8:14283\u201393.","journal-title":"Int J Clin Exp Pathol"},{"key":"1185_CR29","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1111\/j.1365-2559.2009.03421.x","volume":"55","author":"I Zlobec","year":"2009","unstructured":"Zlobec I, G\u00fcnthert U, Tornillo L, et al. Systematic assessment of the prognostic impact of membranous CD44v6 protein expression in colorectal cancer. Histopathology. 2009;55:564\u201375. https:\/\/doi.org\/10.1111\/j.1365-2559.2009.03421.x.","journal-title":"Histopathology"},{"key":"1185_CR30","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3892\/ol.2021.13081","volume":"22","author":"A Kataki","year":"2021","unstructured":"Kataki A, Giannakoulis VG, Derventzi A, Papiris K, Koniaris E, Konstadoulakis M. Membranous CD44v6 is upregulated as an early event in colorectal cancer: downregulation is associated with circulating tumor cells and poor prognosis. Oncol Lett. 2021;22:820. https:\/\/doi.org\/10.3892\/ol.2021.13081.","journal-title":"Oncol Lett"},{"key":"1185_CR31","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1016\/j.athoracsur.2005.12.054","volume":"81","author":"DR Jones","year":"2006","unstructured":"Jones DR, Daniel TM, Denlinger CE, Rundall BK, Smolkin ME, Wick MR. Stage IB nonsmall cell lung cancers: are they all the same? Ann Thorac Surg. 2006;81:1958\u201362. https:\/\/doi.org\/10.1016\/j.athoracsur.2005.12.054.","journal-title":"Ann Thorac Surg"},{"key":"1185_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/thx.2008.110825","volume":"65","author":"JJ Hung","year":"2010","unstructured":"Hung JJ, Jeng WJ, Hsu WH, et al. Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis. Thorax. 2010;65:241\u20135. https:\/\/doi.org\/10.1136\/thx.2008.110825.","journal-title":"Thorax"},{"key":"1185_CR33","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1097\/JTO.0b013e31824cbad8","volume":"7","author":"JJ Hung","year":"2012","unstructured":"Hung JJ, Jeng WJ, Hsu WH, Chou TY, Huang BS, Wu YC. Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. J Thorac Oncol. 2012;7:1115\u201323. https:\/\/doi.org\/10.1097\/JTO.0b013e31824cbad8.","journal-title":"J Thorac Oncol"},{"key":"1185_CR34","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0003-4975(95)00537-u","volume":"60","author":"RJ Ginsberg","year":"1995","unstructured":"Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung cancer study group. Ann Thorac Surg. 1995;60:615\u201322. https:\/\/doi.org\/10.1016\/0003-4975(95)00537-u.","journal-title":"Ann Thorac Surg"},{"key":"1185_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12885-020-6621-1","volume":"20","author":"C Wang","year":"2020","unstructured":"Wang C, Wu Y, Shao J, Liu D, Li W. Clinicopathological variables influencing overall survival, recurrence and post-recurrence survival in resected stage I non-small-cell lung cancer. BMC Cancer. 2020;20:150. https:\/\/doi.org\/10.1186\/s12885-020-6621-1.","journal-title":"BMC Cancer"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01185-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01185-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01185-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T11:18:38Z","timestamp":1702725518000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01185-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":35,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1185"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01185-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2681347\/v1","asserted-by":"object"}]},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"11 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Institutional Review Board of Kagawa University in Japan.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The requirement for informed consent was waived owing to the retrospective nature of the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}